Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 50, 2020 - Issue 4
308
Views
3
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Reduced systemic exposure and brain uptake of donepezil in rats with scopolamine-induced cognitive impairment

, ORCID Icon, , , & ORCID Icon
Pages 389-400 | Received 04 Jun 2019, Accepted 10 Jul 2019, Published online: 01 Aug 2019

References

  • Abcam. (2018). Instructions for use acetylcholinesterase assay kit [online]. Abcam. Available from: https://www.abcam.com/acetylcholinesterase-assay-kit-colorimetric-ab138871-protocols.html#top-341 [last accessed 29 May 2019].
  • Bhateria M, Ramakrishna R, Pakala DB, et al. (2015). Development of an LC-MS/MS method for simultaneous determination of memantine and donepezil in rat plasma and its application to pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 1001:131–9.
  • Chen BH, Park JH, Kim DW, et al. (2018). Melatonin improves cognitive deficits via restoration of cholinergic dysfunction in a mouse model of scopolamine-induced amnesia. ACS Chem Neurosci 9:2016–24.
  • Ellman GL, Courtney KD, Andres V, Jr, et al. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95.
  • Food and Drug Administration. (2005). Guidance for industry estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers [online]. Food and Drug Administration. Available from: https: //www.fda.gov/media/72309/download [last accessed 29 May 2019].
  • Food and Drug Administration. (2018). Guidance for industry bioanalytical method validation [online]. Food and Drug Administration. Available from: https://www.fda.gov/downloads/drugs/guidances/ucm070107.pdf [last accessed 29 May 2019].
  • Funaki Y, Kato M, Iwata R, et al. (2003). Evaluation of the binding characteristics of [5-(11)C-methoxy]Donepezil in the rat brain for in vivo visualization of acetylcholinesterase. J Pharmacol Sci 91:105–12.
  • Goh CW, Aw CC, Lee JH, et al. (2011). Pharmacokinetic and pharmacodynamic properties of cholinesterase inhibitors donepezil, tacrine, and galantamine in aged and young Lister hooded rats. Drug Metab Dispos 39:402–11.
  • Hosseini M, Mohammadpour T, Karami R, et al. (2015). Effects of the hydro-alcoholic extract of Nigella sativa on scopolamine-induced spatial memory impairment in rats and its possible mechanism. Chin J Integr Med 21:438–44.
  • Ionita R, Postu PA, Beppe GJ, et al. (2017). Cognitive-enhancing and antioxidant activities of the aqueous extract from Markhamia tomentosa (Benth.) K. Schum. stem bark in a rat model of scopolamine. Behav Brain Funct 13:5.
  • Kasa P, Papp H, Kasa P, Jr, et al. (2000). Donepezil dose-dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain. Neuroscience 101:89–100.
  • Khuroo AH, Gurule SJ, Monif T, et al. (2012). ESI-MS/MS stability-indicating bioanalytical method development and validation for simultaneous estimation of donepezil, 5-desmethyl donepezil and 6-desmethyl donepezil in human plasma. Biomed Chromatogr 26:636–49.
  • Klinkenberg I, Blokland A. (2010). The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev 34:1307–50.
  • Kosasa T, Kuriya Y, Matsui K, et al. (2000). Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats. Eur J Pharmacol 389:173–9.
  • Lee B, Sur B, Shim J, et al. (2014). Acupuncture stimulation improves scopolamine-induced cognitive impairment via activation of cholinergic system and regulation of BDNF and CREB expressions in rats. BMC Complement Altern Med 14: 338.
  • Lv C, Li Q, Zhang Y, et al. (2013). A UFLC-MS/MS method with a switching ionization mode for simultaneous quantitation of polygalaxanthone III, four ginsenosides and tumulosic acid in rat plasma: application to a comparative pharmacokinetic study in normal and Alzheimer's disease rats. J Mass Spectrom 48:904–13.
  • Mano Y, Hotta K, Kusano K. (2016). Simultaneous determination of donepezil and its three metabolites in human plasma using LC-MS-MS. J Chromatogr Sci 54:1328–35.
  • Marshall K, Fritz K, Thom W, et al. (2012). Toxic interaction between fluoxetine and donepezil: a case of cholinergic toxidrome. J Neuropsychiatry Clin Neurosci 24:E50.
  • Matsui K, Mishima M, Nagai Y, et al. (1999). Absorption, distribution, metabolism, and excretion of donepezil (Aricept) after a single oral administration to Rat. Drug Metab Dispos 27:1406–14.
  • Medicine and Healthcare Products Regulatory Agency. (2010). Donepezil hydrochloride 5 mg and 10 mg film-coated tablet [online]. Medicine and Healthcare Products Regulatory Agency. Available from: http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con081897.pdf [last accessed 29 May 2019].
  • Ngoupaye GT, Pahaye DB, Ngondi J, et al. (2017). Gladiolus dalenii lyophilisate reverses scopolamine-induced amnesia and reduces oxidative stress in rat brain. Biomed Pharmacother 91:350–7.
  • Ozarowski M, Mikolajczak PL, Piasecka A, et al. (2017). Effect of Salvia miltiorrhiza root extract on brain acetylcholinesterase and butyrylcholinesterase activities, their mRNA levels and memory evaluation in rats. Physiol Behav 173:223–30.
  • Patel BN, Sharma N, Sanyal M, et al. (2008). Quantitation of donepezil and its active metabolite 6-O-desmethyl donepezil in human plasma by a selective and sensitive liquid chromatography-tandem mass spectrometric method. Anal Chim Acta 629:145–57.
  • Pilli NR, Inamadugu JK, Kondreddy N, et al. (2011). A rapid and sensitive LC-MS/MS method for quantification of donepezil and its active metabolite, 6-O-desmethyl donepezil in human plasma and its pharmacokinetic application. Biomed Chromatogr 25:943–51.
  • Pollock D, Cunningham E, Mcguinness B, et al. (2017). Pisa syndrome due to donepezil: pharmacokinetic interactions to blame? Age Ageing 46:529–30.
  • Putcha L, Cintron NM, Tsui J, et al. (1989). Pharmacokinetics and oral bioavailability of scopolamine in normal subjects. Pharm Res 6:481–5.
  • Qu Z, Zhang J, Yang H, et al. (2017). Prunella vulgaris L., an edible and medicinal plant, attenuates scopolamine-induced memory impairment in rats. J Agric Food Chem 65:291–300.
  • Renaud B, Denoroy L, Collin-Chavagnac D, et al. 2018. Clinical CNS microdialysis of glutamate with a special methodological focus on human spinal cord. In: S. Parrot and L. Denoroy, eds. Biochemical approaches for glutamatergic neurotransmission. New York, NY: Springer New York, 523–58.
  • Rogers SL, Doody RS, Mohs RC, et al. (1998). Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med 158:1021–31.
  • Ruela ALM, Santos MG, Figueiredo EC, et al. (2014). LC-PDA and LC-MS studies of donepezil hydrochloride degradation behaviour in forced stress conditions %. J Brazilian Chem Soc 25:2094–101.
  • Shi X, Tang Y, Zhu H, et al. (2014). Comparative tissue distribution profiles of five major bio-active components in normal and blood deficiency rats after oral administration of Danggui Buxue Decoction by UPLC-TQ/MS. J Pharm Biomed Anal 88:207–15.
  • Sugimoto H, Ogura H, Arai Y, et al. (2002). Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor. Jpn J Pharmacol 89:7–20.
  • Van Dam D, De Deyn PP. (2011). Animal models in the drug discovery pipeline for Alzheimer's disease. Br J Pharmacol 164:1285–300.
  • Yang T, Liu S, Wang CH, et al. (2015). Comparative pharmacokinetic and tissue distribution profiles of four major bioactive components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe. J Pharm Biomed Anal 114:152–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.